{'fraction_non_alphanumeric': 0.0463258785942492, 'fraction_numerical': 0.012247071352502662, 'mean_word_length': 6.037453183520599, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Neuregulin‐1 promotes the proliferation, migration, and angiogenesis of human periodontal ligament stem cells in vitro

Neuregulin‐1 (NRG‐1) can promote the proliferation, migration, and angiogenesis of multiple stem cells, as well as prohibit cell apoptosis. In the present study, we aimed to explore the effects of NRG‐1 on the proliferation, migration, apoptosis, angiogenic, and osteogenic differentiation of periodontal ligament stem cells (PDLSCs) in vitro. The expression of erythroblastic leukemia viral oncogene homolog 2 (ERBB2), ERBB3, and ERBB4 on PDLSCs were detected by quantitative real‐time polymerase chain reaction (qRT‐PCR) and immunofluorescence. The effects of NRG‐1 on the proliferation, migration, apoptosis, angiogenic and osteogenic differentiation of PDLSCs were assessed by cell proliferation and viability assays, transwell migration assay, flow cytometry assay, tubule formation assay, alkaline phosphatase (ALP) activity, and Alizarin Red S staining, respectively. Gene expression of angiogenesis and osteogenesis‐related markers were detected by qRT‐PCR. Among the ERBB family members, ERBB2 had the highest expression level in PDLSCs. Further, 10 ng/ml NRG‐1 exhibited the maximal effect on proliferation, migration and remarkably inhibited the apoptosis of PDLSCs (p < .05). Moreover, NRG‐1 upregulated the expression of vascular endothelial growth factor (VEGF), platelet/endothelial cell adhesion molecule‐1 (CD31), hypoxia‐inducible factor (HIF), kinase insert domain‐containing receptor (KDR) in a dose‐dependent manner as well as induced more tube formation. However, NRG‐1 did not affect osteogenesis (p > .05). In summary, our study demonstrated that NRG‐1 promotes the proliferation, migration, and angiogenesis and inhibits the apoptosis of PDLSCs in vitro and can potentially be used in tissue engineering for periodontal regeneration.